Cargando…

Noradrenaline drives immunosuppression in sepsis: clinical consequences

Detalles Bibliográficos
Autores principales:	Stolk, Roeland F., Kox, Matthijs, Pickkers, Peter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2020
Materias:	What's New in Intensive Care
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7292809/ https://www.ncbi.nlm.nih.gov/pubmed/32270211 http://dx.doi.org/10.1007/s00134-020-06025-2

Ejemplares similares

What’s new in the extracorporeal treatment of sepsis?
por: Pickkers, Peter, et al.
Publicado: (2017)

Is this critically ill patient immunocompromised?
por: Pène, Frédéric, et al.
Publicado: (2015)

New drugs for acute kidney injury
por: Pickkers, Peter, et al.
Publicado: (2022)

COVID-19: 10 things I wished I’d known some months ago
por: Pickkers, Peter, et al.
Publicado: (2020)

The ten pitfalls of lactate clearance in sepsis
por: Hernandez, Glenn, et al.
Publicado: (2018)

Paediatric sepsis: old wine in new bottles?
por: Schlapbach, Luregn J., et al.
Publicado: (2017)

What’s new in sepsis recognition in resource-limited settings?
por: Kwizera, Arthur, et al.
Publicado: (2016)

Ventilatory support of patients with sepsis or septic shock in resource-limited settings
por: Serpa Neto, Ary, et al.
Publicado: (2015)

Recommendations for infection management in patients with sepsis and septic shock in resource-limited settings
por: Thwaites, C. Louise, et al.
Publicado: (2016)

What’s new in bacterial meningitis
por: Brouwer, Matthijs C., et al.
Publicado: (2016)

Core elements of general supportive care for patients with sepsis and septic shock in resource-limited settings
por: Mer, Mervyn, et al.
Publicado: (2017)

A double-blind, placebo-controlled, randomised, multicentre, proof-of-concept and dose-finding phase II clinical trial to investigate the safety, tolerability and efficacy of adrecizumab in patients with septic shock and elevated adrenomedullin concentration (AdrenOSS-2)
por: Geven, Christopher, et al.
Publicado: (2019)

Adaptive designs in clinical trials in critically ill patients: principles, advantages and pitfalls
por: van Werkhoven, C. H., et al.
Publicado: (2018)

Ten recommendations for child-friendly visiting policies in critical care
por: Brauchle, Maria, et al.
Publicado: (2023)

What’s new about circulating biomarkers in pediatric acute lung disease
por: Moreira, Amélia, et al.
Publicado: (2016)

Future therapies for ARDS
por: Curley, Gerard F., et al.
Publicado: (2014)

Airborne spread of SARS-CoV-2 while using high-flow nasal cannula oxygen therapy: myth or reality?
por: Haymet, Andrew, et al.
Publicado: (2020)

Intensive care for COVID-19 in low- and middle-income countries: research opportunities and challenges
por: Salluh, Jorge I. F., et al.
Publicado: (2020)

Updated nomenclature of delirium and acute encephalopathy: statement of ten Societies
por: Slooter, Arjen J. C., et al.
Publicado: (2020)

Antimicrobial stewardship in ICUs during the COVID-19 pandemic: back to the 90s?
por: De Waele, Jan J., et al.
Publicado: (2020)

Ten things the hematologist wants you to know about CAR-T cells
por: Böll, Boris, et al.
Publicado: (2020)

Monitoring patient–ventilator interaction by an end-expiratory occlusion maneuver
por: Dianti, Jose, et al.
Publicado: (2020)

Ten things we learned about COVID-19
por: Cecconi, Maurizio, et al.
Publicado: (2020)

Airway closure, more harmful than atelectasis in intensive care?
por: Hedenstierna, Göran, et al.
Publicado: (2020)

What have we learned from animal models of ventilator-induced lung injury?
por: Rocco, Patricia Rieken Macedo, et al.
Publicado: (2020)

What is new in non-ventilated ICU-acquired pneumonia?
por: Saied, Wafa Ibn, et al.
Publicado: (2020)

What’s new in lung ultrasound during the COVID-19 pandemic
por: Volpicelli, Giovanni, et al.
Publicado: (2020)

Facing COVID-19 in the ICU: vascular dysfunction, thrombosis, and dysregulated inflammation
por: Leisman, Daniel E., et al.
Publicado: (2020)

Ten reasons for focusing on the care we provide for family members of critically ill patients with COVID-19
por: Azoulay, Élie, et al.
Publicado: (2020)

COVID-19: a novel coronavirus and a novel challenge for critical care
por: Arabi, Yaseen M., et al.
Publicado: (2020)

Critical care crisis and some recommendations during the COVID-19 epidemic in China
por: Xie, Jianfeng, et al.
Publicado: (2020)

Severe SARS-CoV-2 infections: practical considerations and management strategy for intensivists
por: Bouadma, Lila, et al.
Publicado: (2020)

Novel coronavirus infection during the 2019–2020 epidemic: preparing intensive care units—the experience in Sichuan Province, China
por: Liao, Xuelian, et al.
Publicado: (2020)

What’s new about pulmonary hyperinflation in mechanically ventilated critical patients
por: Vassilakopoulos, Theodoros, et al.
Publicado: (2020)

What’s new in subarachnoid hemorrhage
por: Smith, M., et al.
Publicado: (2014)

What’s new in ARDS: ARDS also exists in resource-constrained settings
por: Riviello, Elisabeth D., et al.
Publicado: (2016)

What’s new on the HPA axis?
por: Hofland, Johannes, et al.
Publicado: (2015)

Pre-hospital transportation in Western countries for Ebola patients, comparison of guidelines
por: Coignard-Biehler, H., et al.
Publicado: (2015)

What’s new in the management of severe acute pancreatitis?
por: Mallédant, Yannick, et al.
Publicado: (2015)

Goal-concordant care in the ICU: a conceptual framework for future research
por: Turnbull, Alison E., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_tupa0i3dkof2ff0tpmvknvika5